Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Maryland: The Definitive Guide for Patients and Families

We understand that for many women in Maryland, the journey toward breast reconstruction or enhancement was supposed to be a chapter of healing, restoration, or newfound confidence. Whether you are a breast cancer survivor who sought reconstruction at one of our world-tier institutions like the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center in Baltimore or a patient in Bethesda seeking revision surgery, the expectation was trust. You trusted your surgeon, the hospital, and, most importantly, the manufacturers of the medical devices placed inside your body.

When those devices fail—whether they are acellular dermal matrices (ADM), synthetic meshes, or bioabsorbable scaffolds used in “internal bra” techniques—the fallout is more than just a medical complication. It is a profound violation of your physical autonomy and your future. At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we represent women in Maryland who have been catastrophically injured by defective breast mesh products that were never actually approved by the FDA for use in the breast.

If you are experiencing symptoms like chronic pain, redness, late-onset swelling, or the failure of your reconstruction, you deserve to know that the law provides a pathway for accountability. Under the leadership of our Managing Partner, Ralph Manginello, who has practiced for twenty-seven years, and Associate Attorney Lupe Peña, we provide the hyper-technical legal and scientific advocacy required to take on global device manufacturers. We are admitted to the United States District Court and are currently prosecuting high-profile institutional liability cases, such as the $10,000,000 Bermudez v. Pi Kappa Phi litigation, proving our capacity to handle complex multi-defendant actions.

We invite you to examine this resource closely. This is not a brochure; it is the definitive educational guide for Maryland patients, designed to help you understand the regulatory failures, the pathology of your injuries, and your rights under the law. When you are ready to talk, call us at 1-888-ATTY-911 for a confidential, no-obligation consultation.

The Regulatory Reality: What Maryland Patients Weren’t Told

One of the most startling facts for patients in Maryland is that the surgical mesh, ADM, and scaffolds used in their breast surgeries were often used “off-label.” While surgeons are permitted to use devices in ways they believe help their patients, manufacturers are prohibited from promoting these products for unapproved uses.

The 510(k) Shortcut and “Predicate Creep”

Most breast mesh products, including the popular GalaFLEX scaffold and Phasix mesh, entered the market through the FDA’s 510(k) clearance pathway (21 USC §360c). Unlike the Premarket Approval (PMA) process required for higher-risk Class III devices, 510(k) clearance does not require the manufacturer to prove the device is “safe and effective.” They only need to show it is “substantially equivalent” to a “predicate device” already on the market.

In a phenomenon known as “predicate creep,” modern breast scaffolds like GalaFLEX traced their equivalence back to surgical sutures—a fundamentally different medical use. We often explain to our Maryland clients that their bodies were essentially used as a testing ground for materials never clinically validated for the complex environment of the breast envelope.

Verbatim FDA Warnings

In a landmark letter to healthcare providers on November 9, 2023, the FDA stated explicitly: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This letter specifically named Becton Dickinson (BD) products like GalaFLEX and Phasix, requiring labeling updates to reflect that no surgical mesh products have been cleared or approved for breast surgery.

For a woman in Baltimore or Silver Spring who was told her “internal bra” mesh was the “Gold Standard,” this regulatory admission is the foundation of a failure-to-warn claim. At Attorney911, we use these federal records to pierce the corporate defense that these products were “FDA cleared” as a synonym for “safe.”

Identifying the Defective Products Used in Maryland Surgeries

If you underwent surgery in Maryland, your operative report may contain brand names that carry significant legal and medical implications. We assist our clients in retrieving these records and identifying exactly what was implanted.

Acellular Dermal Matrix (ADM)

These are biologic materials derived from human or animal skin. Major brands include:

• AlloDerm and AlloDerm RTU (Allergan/AbbVie)
• FlexHD and FlexHD Pliable (MTF Biologics)
• Strattice (Allergan/AbbVie)
• AlloMax (C.R. Bard/Becton Dickinson)
• SurgiMend (Integra LifeSciences)

The FDA issued a safety communication on March 31, 2021, warning that FlexHD and AlloMax showed significantly higher rates of reoperation, infection, and explantation compared to other ADMs.

Bioabsorbable and Synthetic Scaffolds

These are synthetic materials designed to provide temporary support while the body builds its own tissue.

• GalaFLEX (variants include 3D, 3DR, and Lite)
• Phasix Mesh
• DuraSorb
• TIGR Matrix

GalaFLEX, made by Galatea Surgical (a BD subsidiary), is composed of poly-4-hydroxybutyrate (P4HB). While marketed to resorb within 18 to 24 months, we are seeing cases in Maryland where the mesh remains palpable, causes chronic inflammation, or fails prematurely, leading to “bottoming out” of the breast.

High-Profile Advocacy: The Dr. Hooman Noorchashm Whistleblower Record

Our Maryland clients deserve an attorney who understands the intra-corporate dynamics of the manufacturers they are suing. We closely follow the record of Dr. Hooman Noorchashm, the cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD) who became a whistleblower.

Dr. Noorchashm was terminated in 2022 after raising internal alarms regarding the safety of GalaFLEX in breast surgery. His allegations are central to our litigation strategy:

1. Withheld Data: Allegations that BD withheld reports of breast cancer recurrences in GalaFLEX clinical trials from the FDA.
2. MAUDE Reporting Gaps: Allegations that the Manufacturer and User Facility Device Experience (MAUDE) database was missing critical details on hundreds of patient injuries.
3. Off-Label Promotion: Allegations that BD marketed GalaFLEX specifically for breast surgery despite knowing it lacked the requisite safety clearance.

When our Managing Partner, Ralph Manginello, approaches these cases, we do so with the understanding that institutional concealment is often the “smoking gun” in product liability. Our experience with high-stakes litigation, confirmed by our work in the Bermudez fraternity hazing case, allows us to aggressively pursue these “fraud-on-the-surgeon” theories.

The Spectrum of Injury: What Maryland Patients Face

Complications from defective mesh and scaffolds are rarely just “minor setbacks.” They often require multiple revision surgeries, causing physical and emotional trauma to women across Maryland.

Surgical Site Infections and Sepsis

ADM and synthetic meshes can become a breeding ground for bacteria. When these devices are colonized by biofilm, antibiotics are often ineffective, and the entire reconstruction must be explanted. In severe cases, this leads to life-threatening sepsis, requiring emergency care at Maryland hospitals like the University of Maryland Medical Center.

Red Breast Syndrome (RBS)

Unique to ADM products, Red Breast Syndrome is a non-infectious, sterile inflammation of the skin. This is often caused by bacterial endotoxins (lipopolysaccharides) retained on the matrix during manufacturing. While the device is “sterile,” the endotoxin load triggers an immune response that mimics infection.

Reconstruction Failure and Disfigurement

When a scaffold like GalaFLEX fails to provide the promised support, patients may experience “bottoming out,” migration of the implant, or total loss of the reconstruction. For a cancer survivor, this loss can be as psychologically devastating as the original diagnosis.

BIA-ALCL and BIA-SCC

We also represent women in Maryland diagnosed with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a uniquely recognized T-cell lymphoma (CD30+, ALK-) associated primarily with textured surfaces, such as the recalled Allergan BIOCELL implants. More recently, the FDA has warned about Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), an epithelial tumor that forms in the capsule around the device.

If you have been diagnosed with any of these conditions, our firm possesses the pathologic command to translate your medical records into a powerful legal claim.

The Legal Landscape in Maryland: Statutes and Recovery

Navigating a defective device claim in Maryland requires an attorney who understands both federal preemption and Maryland state law.

Federal Preemption and the Riegel Parallel Claim Exception

Medical device manufacturers often try to hide behind federal preemption, citing the Supreme Court case Riegel v. Medtronic (552 U.S. 312). They argue that because the FDA “cleared” the device, they cannot be sued under state law.

However, because these mesh products were cleared via 510(k) (Medtronic v. Lohr, 518 U.S. 470) rather than the stringent PMA process, we can often defeat these defenses. Furthermore, we pursue “parallel claims”—arguing that the manufacturer violated Maryland state law by failing to satisfy federal requirements, such as reporting adverse events to the FDA (21 CFR Part 803).

Maryland’s Statute of Limitations and Repose

In Maryland, the statute of limitations for product liability is generally three years from the date you discovered your injury. Crucially, Maryland also has a statute of repose of 20 years, which can be an important factor for patients whose injuries developed slowly over time. However, every case has unique deadlines. If you were injured in Baltimore, Annapolis, or Rockville, delaying a legal review could result in your claim being permanently barred.

Damages Available to Maryland Survivors

We fight for a full recovery for our clients, including:

• Economic Damages: Coverage for past and future revision surgeries, hospital stays, and lost wages.
• Non-Economic Damages: Compensation for physical pain, emotional distress, and the permanent loss of the breast or sensation.
• Punitive Damages: In cases where we can prove the manufacturer acted with actual malice or conscious disregard for safety, we may seek exemplary damages.

Why Choose Attorney911 for Your Maryland Mesh Case?

When you are facing a multi-billion-dollar manufacturer like Becton Dickinson or Allergan/AbbVie, you cannot rely on a generalist Maryland personal injury firm. You need a team with deep federal court experience and a proven record of handling institutional liability.

Scientific and Doctrinal Command

We don’t just “handle” cases; we litigate the science. Ralph Manginello and our team stay at the forefront of BIA-ALCL pathology, P4HB hydrolysis kinetics, and the Dr. Noorchashm whistleblower record. We understand the CPT 15777 coverage controversy and how insurers like Cigna are navigating these claims.

Bilingual Representation: Hablamos Español

Maryland is home to a vibrant, diverse population. Our Associate Attorney, Lupe Peña, is a third-generation Texan who conducts full client consultations in fluent Spanish. We believe that language should never be a barrier to justice. If you or a family member in the Montgomery County or Prince George’s County area prefers to discuss your case in Spanish, Lupe is here to ensure your voice is heard without the need for a translator.

Lead Counsel Capability

Our firm’s current role as lead counsel in the $10 million Bermudez v. Pi Kappa Phi case demonstrates our ability to take on powerful institutions—whether they are universities, national fraternities, or medical device conglomerates. We possess the resources to manage the heavy document discovery and expert witness depositions that these cases require.

Third-Party Verification of Excellence

We pride ourselves on our transparency and verified reputation:

• Ralph Manginello: Avvo Rating 8.2 (“Excellent”), Martindale-Hubbell Preeminent Rated, and a member of the Pro Bono College of the State Bar of Texas.
• Client Reviews: We maintain a 4.9 out of 5.0 rating on Birdeye across hundreds of client reviews.
• Civic Engagement: Beyond the courtroom, we are active members of the community, with Ralph’s basketball team recently inducted into the Cheshire Academy Hall of Fame for their 1989-90 championship.

Frequently Asked Questions for Maryland Patients

1. I had my surgery five years ago in Baltimore. Is it too late to sue?

Not necessarily. Maryland follows the “discovery rule,” meaning the three-year clock often starts when you knew—or should have known—that your complications were linked to the defective device. Many Maryland women only realized the link following the 2023 FDA labeling update or the various Allergan recalls. We can evaluate your timeline during a free consultation.

2. Is this a class action?

Most defective device cases are handled as Mass Torts or Multidistrict Litigation (MDL). For example, many textured-implant cases are centralized in MDL 2921 in the District of New Jersey. This allows individual Maryland plaintiffs to maintain their own cases while sharing the costs of discovery against the manufacturer.

3. What if I don’t know the brand of mesh used in my reconstruction?

This is common. We help our Maryland clients request their full “Certified Medical Records” and operative reports. We look for the “Implant Log” or “Device Stickers” that hospitals are required to keep. Once we have the lot number and product code, we can identify the manufacturer.

4. How much does a Maryland breast mesh attorney cost?

We work on a contingency fee basis. This means we charge no upfront fees, and we only get paid if we recover compensation for you. We take on the financial risk of hiring expert pathologists and regulatory consultants so that you can focus on your recovery.

5. My surgeon says the mesh is safe. Can I still have a case?

Yes. Under the “Learned Intermediary Doctrine,” a manufacturer’s primary duty is to warn the surgeon. If the manufacturer misled your surgeon—as is alleged in the GalaFLEX whistleblower cases—the surgeon was also a victim of the manufacturer’s deception. We don’t necessarily have to prove your Maryland surgeon did anything wrong to prove the mesh was defective.

Your Path Forward in Maryland

Whether you are in Baltimore, Bethesda, Annapolis, or a rural community on the Eastern Shore, your location should not dictate your access to high-tier legal representation. If you are suffering from complications related to AlloDerm, GalaFLEX, Phasix, or Allergan BIOCELL implants, you are not alone.

The defense counsel for these companies is already working to minimize your story. They will argue that your complications are “known risks” or that you were a “difficult healer.” We know better. We know that when a manufacturer pushes a device into a woman’s breast without FDA safety screening, they are responsible for the results.

At Attorney911, we fight for Maryland survivors with the same aggression and precision we use in our highest-profile national cases. We offer a compassionate, technically rigorous, and bilingual environment where your health and your rights come first.

Call Us Today: 1-888-ATTY-911

Take the first step toward reclaiming your agency. Call us at 1-888-ATTY-911 (1-888-288-9911) for your free, confidential case evaluation.

Hablamos español. No fee unless we recover for you. Attorney Advertising. The Manginello Law Firm, PLLC. Principal Office: 1177 West Loop South, Suite 1600, Houston, TX 77027. Ralph Manginello is licensed in Texas and admitted to the Southern District of Texas. In Maryland and other jurisdictions, we may associate with local counsel or seek pro hac vice admission to ensure your case is handled with the highest local expertise.

Maryland Regional Medical and Legal Context

If your surgery took place at a major Maryland medical hub, your case may involve records from:

• The Johns Hopkins Hospital (Baltimore)
• University of Maryland Medical Center (Baltimore)
• Luminis Health Anne Arundel Medical Center (Annapolis)
• Holy Cross Hospital (Silver Spring/Germantown)
• MedStar Georgetown University Hospital (serving the Maryland/D.C. border)

These institutions are world-class, but even the best surgeons are dependent on the honesty of device manufacturers. If your “internal bra” or reconstruction is failing, we possess the local fluency to handle cases filed in the United States District Court for the District of Maryland, whether in the Baltimore or Greenbelt divisions.

Maryland women are known for their resilience. We are here to provide the legal strength to match it. Don’t wait for your symptoms to worsen—protect your future today. Call 1-888-ATTY-911.